CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- NT 10-K Other NT 10-K
- EFFECT Other Notice of Effectiveness
- DRS Other Draft Registration Statement
- EFFECT Other Notice of Effectiveness
- NT 10-Q Other NT 10-Q
- D Other Notice of Sales of Unregistered Securities
- NT 10-Q Other NT 10-Q
- DEFR14A Other DEFR14A
- PRER14A Other PRER14A
- ARS Other Annual Report to Security Holders
- NT 10-K Other NT 10-K
- ARS Other Annual Report to Security Holders
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
Page 1 of 4 · 61 filings